Cargando…
The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
PURPOSE: Androgens stimulate the production of hypoxia-inducible factor (HIF1α) and ultimately vascular endothelial growth factor (VEGF-A). Additionally, epithelial growth factor (EGF) mediates HIF1α production. Carbonic anhydrase IX (CAIX) expression is associated with tumor cell hypoxia in a varie...
Autores principales: | Weber, Damien C, Tille, Jean-Christophe, Combescure, Christophe, Egger, Jean-François, Laouiti, Mahomet, Hammad, Karim, Granger, Perrine, Rubbia-Brandt, Laura, Miralbell, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432017/ https://www.ncbi.nlm.nih.gov/pubmed/22546016 http://dx.doi.org/10.1186/1748-717X-7-66 |
Ejemplares similares
-
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
por: Amit, Uri, et al.
Publicado: (2019) -
Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
por: Fortier, Alexa, et al.
Publicado: (2022) -
Patients’ Preferences for Androgen Deprivation Therapy in the
Treatment of Intermediate-Risk Prostate Cancer
por: De, Brian, et al.
Publicado: (2022) -
Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012) -
Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)